Clinical Trial Update: Efficacy, Safety and Tolerability of Ribavirin Monotherapy Followed by Combined Treatment With Ribavirin and Hydroxychloroquine in Patients Infected With Hepatitis C [Phase 1, Phase 2]

View source ↗

Summary

The study evaluated ribavirin monotherapy followed by combined ribavirin and hydroxychloroquine in hepatitis C, and the Phase 1/2 trial was terminated with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Ribavirin (ribavirin)

Snippet

Sponsor: BioLineRx, Ltd. | Conditions: Hepatitis C | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-08-28